Public Citizen will push the FDA to take Crestor (rosuvastatin) off the market

April 2004

The consumer group, Public Citizen, will push the FDA to take Crestor (rosuvastatin) off the market.

They say it causes renal failure and rhabdomyolysis.

Public Citizen has a track record worth noticing. They successfully went after phenylpropanolamine, Rezulin, Trovan.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

whether cholesterol needs to go even lower than previously thought for some patients
Cardiology Public Citizen will push the FDA to take Crestor (rosuvastatin) off the market
Cardiology Caduet (KA-doo-et), a combination of Lipitor and Norvasc
Dermatology Women on Accutane (isotretinoin) are still getting pregnant
Dermatology best treatment for toenail fungus
Some antipsychotics seem to increase the risk of stroke in elderly patients with dementia
Men's Health using testosterone for "male menopause"
Hematology & Oncology More women with breast cancer will be switched from tamoxifen to one of the aromatase inhibitors
Infectious Diseases Suprax (cefixime) will be coming back onto the market
People often ask what works for nighttime leg cramps
Spiriva, a new bronchodilator for chronic obstructive pulmonary disease
Diabetes & Endocrinology Sensipar (cinacalcet), a new drug for dialysis patients
Women's Health the risks for women taking estrogen (Premarin) ALONE
Women's Health which home pregnancy test is best
Storage & Disposal Patients often ask how to dispose of unused or expired meds